Alopecia Areata in Solid Organ Transplant Recipients: A Retrospective Analysis

March 2025 in “ JAAD International ”

I Roman, Miguel Aristizabal, Napat Leeaphorn, Leila Tolaymat, Thaís Pincelli

alopecia areata solid organ transplant recipients tacrolimus immunosuppressant autoimmune response AA SOTRs

Studysummary Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on jaadinternational.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States

63 citations , March 2020 in “Clinical Cosmetic and Investigational Dermatology”

This study suggests that the prevalence of alopecia areata in the US remains similar to high estimates from the 1970s, with significant implications for quality of life.

research Three Cases of Alopecia Following Clinical Islet Transplantation

11 citations , December 2010 in “American journal of transplantation”

This study describes three female islet transplant recipients who unexpectedly developed alopecia areata about 7 years post-transplant, with a possible link to immunosuppressive treatment regimens.

research Alopecia Areata Presenting in Two Kidney-Pancreas Transplant Recipients Taking Cyclosporine

23 citations , October 2005 in “Journal of The American Academy of Dermatology”

This report describes the unexpected development of alopecia areata in kidney-pancreas transplant recipients undergoing cyclosporine-based immunosuppressive therapy, suggesting a complex relationship between the treatment and disease.